Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 321

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

Open access
Trullàs, Joan Carles, Morales-Rull, José Luis, Casado, Jesús, Carrera-Izquierdo, Margarita, Sánchez-Marteles, Marta, Conde-Martel, Alicia, Dávila-Ramos, Melitón Francisco, Llácer, Pau, Salamanca-Bautista, Prado, Pérez-Silvestre, José, Plasín, Miguel Ángel, Cerqueiro, José Manuel, Gil, Paloma, Formiga, Francesc, Manzano, Luis, CLOROTIC trial investigators, Morales, José Luís, Solé, Cristina, Carrera, Margarita, León, Marta, Sánchez, Marta, Horna, Vanesa Garcés, Conde, Alicia, Meneses, Marta Hernández, Dávila, Melitón Fco, Carballo, Carolina Hernández, Casado, Jesús, Zabaleta, Juan Pedro, Iborra, Pau Llàcer, García, Mari Carmen Moreno, Trullàs, Joan Carles, Bisbe, Josep, del Prado Salamanca Bautista, María, Bodas, Óscar Aramburu, Manzano, Luís, Ruiz, Raúl, Silvestre, José Pérez, Plasín, Miguel Ángel, González, José Manuel Cerqueiro, Chivite, David, Formiga, Francesc, Gil, Paloma, Jordana, Rosa, Villalonga, María, Rubio, M Inmaculada Páez, Rodrigo, José Mª Cepeda, Pérez-Barquero, Manuel Montero, Muela, Alberto, Mateos, Lourdes, Grau, Jordi, Armengou, Arola, Herrero, Almudena, López, Raúl Quirós·2023·European Heart Journal

Abstract

Aims: To evaluate whether the addition of hydrochlorothiazide (HCTZ) to intravenous furosemide is a safe and effective strategy for improving diuretic response in acute heart failure (AHF). Methods and results: A prospective, double-blind, placebo-controlled trial, including patients with AHF randomized to receive HCTZ or placebo in addition to an intravenous furosemide regimen. The coprimary endpoints were changes in body weight and patient-reported dyspnoea 72 h after randomization. Secondary outcomes included metrics of diuretic response and mortality/rehospitalizations at 30 and 90 days. Safety outcomes (changes in renal function and/or electrolytes) were also assessed. Two hundred and thirty patients (48% women, 83 years) were randomized. Patients assigned to HCTZ were more likely to lose weight at 72 h than those assigned to placebo [−2.3 vs. −1.5 kg; adjusted estimated difference (notionally 95% confidence interval) −1.14 (−1.84 to −0.42); P = 0.002], but there were no significant differences in patient-reported dyspnoea (area under the curve for visual analogue scale: 960 vs. 720; P = 0.497). These results were similar 96 h after randomization. Patients allocated to HCTZ showed greater 24 h diuresis (1775 vs. 1400 mL; P = 0.05) and weight loss for each 40 mg of furosemide (at 72 and at 96 h) (P < 0.001). Patients assigned to HCTZ more frequently presented impaired renal function (increase in creatinine >26.5 μmoL/L or decrease in eGFR >50%; 46.5 vs. 17.2%; P < 0.001), but hypokalaemia and hypokalaemia were similar between groups. There were no differences in mortality or rehospitalizations. Conclusion: The addition of HCTZ to loop diuretic therapy improved diuretic response in patients with AHF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehac689

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 321

Metadata

Authors
Trullàs, J. C., Morales-Rull, J. L., Casado, J., Carrera-Izquierdo, M., Sánchez-Marteles, M., Conde-Martel, A., Dávila-Ramos, M. F., Llácer, P., Salamanca-Bautista, P., Pérez-Silvestre, J., Plasín, M. Á., Cerqueiro, J. M., Gil, P., Formiga, F., Manzano, L., CLOROTIC trial investigators, Morales, J. L., Solé, C., Carrera, M., León, M., Sánchez, M., Horna, V. G., Conde, A., Meneses, M. H., Dávila, M. F., Carballo, C. H., Casado, J., Zabaleta, J. P., Iborra, P. L., García, M. C. M., Trullàs, J. C., Bisbe, J., del Prado Salamanca Bautista, M., Bodas, Ó. A., Manzano, L., Ruiz, R., Silvestre, J. P., Plasín, M. Á., González, J. M. C., Chivite, D., Formiga, F., Gil, P., Jordana, R., Villalonga, M., Rubio, M. I. P., Rodrigo, J. M. C., Pérez-Barquero, M. M., Muela, A., Mateos, L., Grau, J., Armengou, A., Herrero, A., & López, R. Q.
Venue
European Heart Journal
Published
2022-11-24
Volume
44
Issue
5
Pages
411-421
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4309908777
Cited by
321
References
2
FWCI
39.07
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehac689
The paper
Trullàs, J. C., Morales-Rull, J. L., Casado, J., Carrera-Izquierdo, M., Sánchez-Marteles, M., Conde-Martel, A., Dávila-Ramos, M. F., Llácer, P., Salamanca-Bautista, P., Pérez-Silvestre, J., Plasín, M. Á., Cerqueiro, J. M., Gil, P., Formiga, F., Manzano, L., CLOROTIC trial investigators, Morales, J. L., Solé, C., Carrera, M., . . . López, R. Q. (2023). Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehac689

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.